Sleuthy Google up­start Cal­i­co forges a rare biotech col­lab­o­ra­tion on ag­ing with No­var­tis-backed C4

The elu­sive but wide­ly buzzed about Cal­i­co, a start­up bankrolled by Google to find new ther­a­pies for ag­ing, has hitched up with pro­tein de­gen­er­a­tion-fo­cused C4 Ther­a­peu­tics with plans to em­bark on a 5-year, cross coun­try re­search col­lab­o­ra­tion.

The deal an­nounce­ment is long on over­ar­ch­ing goals, such as a pre­clin­i­cal fo­cus on can­cer, among oth­er ar­eas, but with lit­tle in­sight in­to the num­bers or the work. And that’s just the way Cal­i­co likes to keep it, care­ful­ly cloak­ing its ac­tiv­i­ties more like an IT com­pa­ny than any av­er­age biotech.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.